Selected research
Market Outlook & Growth Opportunities
Global VR Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global VR Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for VR Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for VR Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for VR Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the VR Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the VR Therapy market include KindVR, XRHealth, Corpus VR, Cognihab, RelieVRx, Neuro Rehab VR, PsyTech VR, oVRcome and AppliedVR, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global VR Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of VR Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents VR Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global VR Therapy market.
VR Therapy Segment by Company
KindVR
XRHealth
Corpus VR
Cognihab
RelieVRx
Neuro Rehab VR
PsyTech VR
oVRcome
AppliedVR
Virtually Better
Oxford VR
Amelia
Healium Korea
HoloEyes
HuidaGene
HTC VIVE Health
VR Therapy Segment by Type
Mental Health Therapy
Exposure Therapy for Phobias
Neurorehabilitation
Chronic Pain Management
Children's Behavioral and Attention Training
VR Therapy Segment by Application
Hospital
Clinic
Home Teletherapy
VR Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global VR Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the VR Therapy key companies, revenue, market share, and recent developments.
3. To split the VR Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions VR Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify VR Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze VR Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global VR Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of VR Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of VR Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global VR Therapy industry.
Chapter 3: Detailed analysis of VR Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of VR Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of VR Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. VR Therapy Industry Trends
Table 2. VR Therapy Industry Drivers
Table 3. VR Therapy Industry Opportunities and Challenges
Table 4. VR Therapy Industry Restraints
Table 5. Global VR Therapy Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global VR Therapy Revenue Share by Company (2021-2026)
Table 7. Global VR Therapy Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global VR Therapy Key Company Manufacturing Base & Headquarters
Table 9. Global VR Therapy Company, Product Type & Application
Table 10. Global VR Therapy Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global VR Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of Mental Health Therapy
Table 15. Significant Companies of Exposure Therapy for Phobias
Table 16. Significant Companies of Neurorehabilitation
Table 17. Significant Companies of Chronic Pain Management
Table 18. Significant Companies of Children's Behavioral and Attention Training
Table 19. Global VR Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 20. Global VR Therapy Sales Value by Type (2021-2026) & (US$ Million)
Table 21. Global VR Therapy Sales Value by Type (2027-2032) & (US$ Million)
Table 22. Global VR Therapy Sales Value Share by Type (2021-2026)
Table 23. Global VR Therapy Sales Value Share by Type (2027-2032)
Table 24. Significant Companies of Hospital
Table 25. Significant Companies of Clinic
Table 26. Significant Companies of Home Teletherapy
Table 27. Global VR Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 28. Global VR Therapy Sales Value by Application (2021-2026) & (US$ Million)
Table 29. Global VR Therapy Sales Value by Application (2027-2032) & (US$ Million)
Table 30. Global VR Therapy Sales Value Share by Application (2021-2026)
Table 31. Global VR Therapy Sales Value Share by Application (2027-2032)
Table 32. Global VR Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 33. Global VR Therapy Sales Value by Region (2021-2026) & (US$ Million)
Table 34. Global VR Therapy Sales Value Share by Region (2021-2026)
Table 35. Global VR Therapy Sales Value by Region (2027-2032) & (US$ Million)
Table 36. Global VR Therapy Sales Value Share by Region (2027-2032)
Table 37. Global VR Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global VR Therapy Sales Value by Country (2021-2026) & (US$ Million)
Table 39. Global VR Therapy Sales Value Market Share by Country (2021-2026)
Table 40. Global VR Therapy Sales Value by Country (2027-2032) & (US$ Million)
Table 41. Global VR Therapy Sales Value Market Share by Country (2027-2032)
Table 42. KindVR Company Information
Table 43. KindVR Business Overview
Table 44. KindVR VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 45. KindVR VR Therapy Product Portfolio
Table 46. KindVR Recent Development
Table 47. XRHealth Company Information
Table 48. XRHealth Business Overview
Table 49. XRHealth VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 50. XRHealth VR Therapy Product Portfolio
Table 51. XRHealth Recent Development
Table 52. Corpus VR Company Information
Table 53. Corpus VR Business Overview
Table 54. Corpus VR VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 55. Corpus VR VR Therapy Product Portfolio
Table 56. Corpus VR Recent Development
Table 57. Cognihab Company Information
Table 58. Cognihab Business Overview
Table 59. Cognihab VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 60. Cognihab VR Therapy Product Portfolio
Table 61. Cognihab Recent Development
Table 62. RelieVRx Company Information
Table 63. RelieVRx Business Overview
Table 64. RelieVRx VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. RelieVRx VR Therapy Product Portfolio
Table 66. RelieVRx Recent Development
Table 67. Neuro Rehab VR Company Information
Table 68. Neuro Rehab VR Business Overview
Table 69. Neuro Rehab VR VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. Neuro Rehab VR VR Therapy Product Portfolio
Table 71. Neuro Rehab VR Recent Development
Table 72. PsyTech VR Company Information
Table 73. PsyTech VR Business Overview
Table 74. PsyTech VR VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. PsyTech VR VR Therapy Product Portfolio
Table 76. PsyTech VR Recent Development
Table 77. oVRcome Company Information
Table 78. oVRcome Business Overview
Table 79. oVRcome VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. oVRcome VR Therapy Product Portfolio
Table 81. oVRcome Recent Development
Table 82. AppliedVR Company Information
Table 83. AppliedVR Business Overview
Table 84. AppliedVR VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. AppliedVR VR Therapy Product Portfolio
Table 86. AppliedVR Recent Development
Table 87. Virtually Better Company Information
Table 88. Virtually Better Business Overview
Table 89. Virtually Better VR Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Virtually Better VR Therapy Product Portfolio
Table 91. Virtually Better Recent Development
Table 92. Oxford VR Company Information
Table 93. Oxford VR Business Overview
Table 94. Oxford VR VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 95. Oxford VR VR Therapy Product Portfolio
Table 96. Oxford VR Recent Development
Table 97. Amelia Company Information
Table 98. Amelia Business Overview
Table 99. Amelia VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 100. Amelia VR Therapy Product Portfolio
Table 101. Amelia Recent Development
Table 102. Healium Korea Company Information
Table 103. Healium Korea Business Overview
Table 104. Healium Korea VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 105. Healium Korea VR Therapy Product Portfolio
Table 106. Healium Korea Recent Development
Table 107. HoloEyes Company Information
Table 108. HoloEyes Business Overview
Table 109. HoloEyes VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 110. HoloEyes VR Therapy Product Portfolio
Table 111. HoloEyes Recent Development
Table 112. HuidaGene Company Information
Table 113. HuidaGene Business Overview
Table 114. HuidaGene VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 115. HuidaGene VR Therapy Product Portfolio
Table 116. HuidaGene Recent Development
Table 117. HTC VIVE Health Company Information
Table 118. HTC VIVE Health Business Overview
Table 119. HTC VIVE Health VR Therapy Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 120. HTC VIVE Health VR Therapy Product Portfolio
Table 121. HTC VIVE Health Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Authors List of This Report
Table 124. Secondary Sources
Table 125. Primary Sources
List of Figures
Figure 1. VR Therapy Product Image
Figure 2. Global VR Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global VR Therapy Market Size (2021-2032) & (US$ Million)
Figure 4. Global VR Therapy Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. Mental Health Therapy Image
Figure 8. Exposure Therapy for Phobias Image
Figure 9. Neurorehabilitation Image
Figure 10. Chronic Pain Management Image
Figure 11. Children's Behavioral and Attention Training Image
Figure 12. Global VR Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global VR Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 14. Global VR Therapy Sales Value Share by Type (2021-2032)
Figure 15. Hospital Image
Figure 16. Clinic Image
Figure 17. Home Teletherapy Image
Figure 18. Global VR Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 19. Global VR Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 20. Global VR Therapy Sales Value Share by Application (2021-2032)
Figure 21. Global VR Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 22. Global VR Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 23. North America VR Therapy Sales Value (2021-2032) & (US$ Million)
Figure 24. North America VR Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 25. Europe VR Therapy Sales Value (2021-2032) & (US$ Million)
Figure 26. Europe VR Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 27. Asia-Pacific VR Therapy Sales Value (2021-2032) & (US$ Million)
Figure 28. Asia-Pacific VR Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 29. South America VR Therapy Sales Value (2021-2032) & (US$ Million)
Figure 30. South America VR Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 31. Middle East & Africa VR Therapy Sales Value (2021-2032) & (US$ Million)
Figure 32. Middle East & Africa VR Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 33. USA VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. USA VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. USA VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Canada VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Canada VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Canada VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Mexico VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Mexico VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Mexico VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. Germany VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. Germany VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. Germany VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. France VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. France VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. France VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. U.K. VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. U.K. VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. U.K. VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Italy VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Italy VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Italy VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Spain VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Spain VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Spain VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Russia VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Russia VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Russia VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Netherlands VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Netherlands VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Netherlands VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. Nordic Countries VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. Nordic Countries VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. Nordic Countries VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. China VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. China VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. China VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. Japan VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. Japan VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. Japan VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. South Korea VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. South Korea VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. South Korea VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. India VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. India VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. India VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Australia VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Australia VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Australia VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Southeast Asia VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Southeast Asia VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Southeast Asia VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Brazil VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Brazil VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Brazil VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Argentina VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Argentina VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Argentina VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Chile VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Chile VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Chile VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Colombia VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Colombia VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Colombia VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Peru VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Peru VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Peru VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Saudi Arabia VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Saudi Arabia VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Saudi Arabia VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. Israel VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. Israel VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. Israel VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. UAE VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. UAE VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. UAE VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Turkey VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Turkey VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Turkey VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Iran VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Iran VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Iran VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Egypt VR Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 115. Egypt VR Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 116. Egypt VR Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 117. Years Considered
Figure 118. Research Process
Figure 119. Key Executives Interviewed
Scope & coverage.
Types
- Mental Health Therapy
- Exposure Therapy for Phobias
- Neurorehabilitation
- Chronic Pain Management
- Children's Behavioral and Attention Training
Applications
- Hospital
- Clinic
- Home Teletherapy
Companies covered
- KindVR
- XRHealth
- Corpus VR
- Cognihab
- RelieVRx
- Neuro Rehab VR
- PsyTech VR
- oVRcome
- AppliedVR
- Virtually Better
- Oxford VR
- Amelia
- Healium Korea
- HoloEyes
- HuidaGene
- HTC VIVE Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global VR Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global VR Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 VR Therapy Market Dynamics
- 2.1 VR Therapy Industry Trends
- 2.2 VR Therapy Industry Drivers
- 2.3 VR Therapy Industry Opportunities and Challenges
- 2.4 VR Therapy Industry Restraints
3 VR Therapy Market by Company
- 3.1 Global VR Therapy Company Revenue Ranking in 2025
- 3.2 Global VR Therapy Revenue by Company (2021-2026)
- 3.3 Global VR Therapy Company Ranking (2024-2026)
- 3.4 Global VR Therapy Company Manufacturing Base and Headquarters
- 3.5 Global VR Therapy Company Product Type and Application
- 3.6 Global VR Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global VR Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 VR Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 VR Therapy Market by Type
- 4.1 VR Therapy Type Introduction
- 4.1.1 Mental Health Therapy
- 4.1.2 Exposure Therapy for Phobias
- 4.1.3 Neurorehabilitation
- 4.1.4 Chronic Pain Management
- 4.1.5 Children's Behavioral and Attention Training
- 4.2 Global VR Therapy Sales Value by Type
- 4.2.1 Global VR Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global VR Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global VR Therapy Sales Value Share by Type (2021-2032)
5 VR Therapy Market by Application
- 5.1 VR Therapy Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Home Teletherapy
- 5.2 Global VR Therapy Sales Value by Application
- 5.2.1 Global VR Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global VR Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global VR Therapy Sales Value Share by Application (2021-2032)
6 VR Therapy Regional Value Analysis
- 6.1 Global VR Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global VR Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global VR Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global VR Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America VR Therapy Sales Value (2021-2032)
- 6.3.2 North America VR Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe VR Therapy Sales Value (2021-2032)
- 6.4.2 Europe VR Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific VR Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific VR Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America VR Therapy Sales Value (2021-2032)
- 6.6.2 South America VR Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa VR Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa VR Therapy Sales Value Share by Country, 2025 VS 2032
7 VR Therapy Country-level Value Analysis
- 7.1 Global VR Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global VR Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global VR Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global VR Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA VR Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada VR Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico VR Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany VR Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France VR Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. VR Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy VR Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain VR Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia VR Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands VR Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries VR Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China VR Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan VR Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea VR Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India VR Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia VR Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia VR Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil VR Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina VR Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile VR Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia VR Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru VR Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia VR Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel VR Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE VR Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey VR Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran VR Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran VR Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt VR Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt VR Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt VR Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 KindVR
- 8.1.1 KindVR Company Information
- 8.1.2 KindVR Business Overview
- 8.1.3 KindVR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 KindVR VR Therapy Product Portfolio
- 8.1.5 KindVR Recent Developments
- 8.2 XRHealth
- 8.2.1 XRHealth Company Information
- 8.2.2 XRHealth Business Overview
- 8.2.3 XRHealth VR Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 XRHealth VR Therapy Product Portfolio
- 8.2.5 XRHealth Recent Developments
- 8.3 Corpus VR
- 8.3.1 Corpus VR Company Information
- 8.3.2 Corpus VR Business Overview
- 8.3.3 Corpus VR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 Corpus VR VR Therapy Product Portfolio
- 8.3.5 Corpus VR Recent Developments
- 8.4 Cognihab
- 8.4.1 Cognihab Company Information
- 8.4.2 Cognihab Business Overview
- 8.4.3 Cognihab VR Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 Cognihab VR Therapy Product Portfolio
- 8.4.5 Cognihab Recent Developments
- 8.5 RelieVRx
- 8.5.1 RelieVRx Company Information
- 8.5.2 RelieVRx Business Overview
- 8.5.3 RelieVRx VR Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 RelieVRx VR Therapy Product Portfolio
- 8.5.5 RelieVRx Recent Developments
- 8.6 Neuro Rehab VR
- 8.6.1 Neuro Rehab VR Company Information
- 8.6.2 Neuro Rehab VR Business Overview
- 8.6.3 Neuro Rehab VR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Neuro Rehab VR VR Therapy Product Portfolio
- 8.6.5 Neuro Rehab VR Recent Developments
- 8.7 PsyTech VR
- 8.7.1 PsyTech VR Company Information
- 8.7.2 PsyTech VR Business Overview
- 8.7.3 PsyTech VR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 PsyTech VR VR Therapy Product Portfolio
- 8.7.5 PsyTech VR Recent Developments
- 8.8 oVRcome
- 8.8.1 oVRcome Company Information
- 8.8.2 oVRcome Business Overview
- 8.8.3 oVRcome VR Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 oVRcome VR Therapy Product Portfolio
- 8.8.5 oVRcome Recent Developments
- 8.9 AppliedVR
- 8.9.1 AppliedVR Company Information
- 8.9.2 AppliedVR Business Overview
- 8.9.3 AppliedVR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 AppliedVR VR Therapy Product Portfolio
- 8.9.5 AppliedVR Recent Developments
- 8.10 Virtually Better
- 8.10.1 Virtually Better Company Information
- 8.10.2 Virtually Better Business Overview
- 8.10.3 Virtually Better VR Therapy Revenue and Gross Margin (2021-2026)
- 8.10.4 Virtually Better VR Therapy Product Portfolio
- 8.10.5 Virtually Better Recent Developments
- 8.11 Oxford VR
- 8.11.1 Oxford VR Company Information
- 8.11.2 Oxford VR Business Overview
- 8.11.3 Oxford VR VR Therapy Revenue and Gross Margin (2021-2026)
- 8.11.4 Oxford VR VR Therapy Product Portfolio
- 8.11.5 Oxford VR Recent Developments
- 8.12 Amelia
- 8.12.1 Amelia Company Information
- 8.12.2 Amelia Business Overview
- 8.12.3 Amelia VR Therapy Revenue and Gross Margin (2021-2026)
- 8.12.4 Amelia VR Therapy Product Portfolio
- 8.12.5 Amelia Recent Developments
- 8.13 Healium Korea
- 8.13.1 Healium Korea Company Information
- 8.13.2 Healium Korea Business Overview
- 8.13.3 Healium Korea VR Therapy Revenue and Gross Margin (2021-2026)
- 8.13.4 Healium Korea VR Therapy Product Portfolio
- 8.13.5 Healium Korea Recent Developments
- 8.14 HoloEyes
- 8.14.1 HoloEyes Company Information
- 8.14.2 HoloEyes Business Overview
- 8.14.3 HoloEyes VR Therapy Revenue and Gross Margin (2021-2026)
- 8.14.4 HoloEyes VR Therapy Product Portfolio
- 8.14.5 HoloEyes Recent Developments
- 8.15 HuidaGene
- 8.15.1 HuidaGene Company Information
- 8.15.2 HuidaGene Business Overview
- 8.15.3 HuidaGene VR Therapy Revenue and Gross Margin (2021-2026)
- 8.15.4 HuidaGene VR Therapy Product Portfolio
- 8.15.5 HuidaGene Recent Developments
- 8.16 HTC VIVE Health
- 8.16.1 HTC VIVE Health Company Information
- 8.16.2 HTC VIVE Health Business Overview
- 8.16.3 HTC VIVE Health VR Therapy Revenue and Gross Margin (2021-2026)
- 8.16.4 HTC VIVE Health VR Therapy Product Portfolio
- 8.16.5 HTC VIVE Health Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst